The Patent Finder

Tiziana Life Sciences PLC

Also on record
Records under this name other than the patents Tiziana Life Sciences PLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Back to Tiziana Life Sciences PLC

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
16/876,839ANTI-CD3 Antibody Formulations
Abandoned
Abandoned Mar 18, 2025
AbandonedAbandoned Mar 18, 2025
16/914,703Formulations of Milciclib and Therapeutic Combinations of the Same for Use in the Treatment of Cancer
Abandoned
Abandoned Nov 18, 2023
AbandonedAbandoned Nov 18, 2023
17/197,603Compositions of IL-6/IL-6R Antibodies and Methods of Use Thereof
Abandoned
Abandoned Nov 19, 2024
AbandonedAbandoned Nov 19, 2024
17/290,527Composition and Methods of Treating Inflammatory and Autoimmune Diseases
Abandoned
Abandoned Nov 29, 2024
AbandonedAbandoned Nov 29, 2024
17/723,098Subcutaneous Administration of Antibodies for the Treatment of Disease
Abandoned
Abandoned Sep 8, 2025
AbandonedAbandoned Sep 8, 2025
17/927,460Compositions and Methods for Augmenting Chimeric Antigen Receptor (CAR) T Cell Therapies
Abandoned
Abandoned Aug 7, 2026
AbandonedAbandoned Aug 7, 2026
18/002,591CD-3 Antibodies for the Treatment of Coronavirus
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/317,810Unit Dose Devices for Nasal Administration of Foralumab
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/494,411Formulations of Milciclib and Therapeutic Combinations of the Same for Use in the Treatment of Cancer
Abandoned
Abandoned Oct 26, 2026
AbandonedAbandoned Oct 26, 2026
18/682,324Combination Therapy for the Treatment of Pan-Kras Mutated Cancers
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
10 of 19 records shown.
Pro members see all 19.
Pro members: see all 19 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited